North America Infusion Pumps Market Size, Share, and Trends Analysis Report
Market Size in USD Billion
CAGR :
% 
USD
17.57 Billion
USD
37.66 Billion
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 17.57 Billion |
 Market Size (Forecast Year) |
USD 37.66 Billion |
 CAGR |
% |
| Major Markets Players |
|
North America Infusion Pumps Market Segmentation, By Type (Ambulatory Pumps, Volumetric Pumps, Syringe Pumps and Accessories), Application (Diabetes, Chemotherapy, Gastrointestinal Diseases and Pediatrics), End User (Hospitals & Clinics, Ambulatory Surgical Centers and Homecare) – Industry Trends and Forecast to 2031.
North America Infusion Pumps Market Size
- The North America Infusion Pumps market size was valued atUSD 17.57 billion in 2024and is expected to reachUSD 37.66 billion by 2032, at aCAGR of 10.00%during the forecast period
- This growth is driven by factors such as the increasing prevalence of chronic diseases, the growing geriatric population, advancements in infusion pump technology, the rise in outpatient and home healthcare settings, and the demand for more precise and customizable drug delivery systems
North America Infusion Pumps Market Analysis
- The North America infusion pumps market is expanding due to the increased use of advanced systems in healthcare facilities, enhancing precision and patient safety
- The demand for home healthcare solutions is rising, with infusion pumps playing a crucial role in managing chronic conditions at home, such as chemotherapy or pain management
- North America is expected to dominate the North America infusion pumps market with 56.11% share due to its well-established healthcare system and cutting-edge medical technology, which drives the demand for advanced medical devices like infusion pumps
- Mexico is expected to be the fastest growing region in the North America infusion pumps market during the forecast period due to substantial investments in healthcare infrastructure and increasing adoption of advanced medical technologies
- The volumetric infusion pumps segment is expected to dominate the North America infusion pumps market with the largest share of 27.49% in 2025 due to their high accuracy in delivering large volumes of fluids, medications, and nutrients at controlled rates. These pumps are widely used in hospitals and clinical settings for critical care, oncology, and long-term therapies, where precise fluid administration is essential
Report Scope and North America Infusion Pumps Market Segmentation
|
Attributes |
North America Infusion Pumps KeyMarket Insights |
|
Segments Covered |
|
|
Countries Covered |
North America
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
North America Infusion Pumps Market Trends
"Smart Technologies Revolutionizing U.S. Infusion Pump Market"
- The U.S. infusion pumps market is seeing a prominent shift towards smart infusion technologies, with increasing integration of advanced software and wireless connectivity in medical devices
- Smart infusion pumps are being adopted to improve medication safety, incorporating features such as real-time monitoring, drug libraries, and error-reducing mechanisms that enhance treatment accuracy
- For instance, in 2024, a leading U.S. hospital network implemented a smart infusion system to ensure better interoperability between infusion pumps and electronic health records, helping to reduce medication administration errors and streamline workflows
- The trend is bolstered by regulatory approvals in the U.S., including the FDA clearance for advanced infusion pumps like the Baxter Novum IQ system, which offers a connected platform for efficient drug delivery across different healthcare environments
- As healthcare facilities in the U.S. increasingly focus on patient safety and operational efficiency, the demand for smart infusion pumps is set to rise, positioning them as a standard in modern healthcare systems
- In conclusion, the growing adoption of smart infusion pumps in the U.S. is enhancing patient safety and streamlining healthcare operations across various medical settings
North America Infusion Pumps Market Dynamics
Driver
“Increasing Prevalence of Chronic Diseases”
- The growing prevalence of chronic diseases in the U.S. is significantly driving the demand for infusion pumps
- Chronic conditions like diabetes, cancer, and cardiovascular diseases require long-term treatment that often involves infusion pumps for fluid, nutrient, and medication administration
- The increasing number of individuals diagnosed with chronic illnesses, particularly among the aging population, has led to greater reliance on infusion pumps for efficient patient care
- Infusion pumps offer precise drug delivery and enhanced patient safety, minimizing human error in administering treatments
- For instance, smart infusion pumps are increasingly being adopted in U.S. hospitals, providing real-time monitoring and alert systems to better manage chronic conditions like diabetes and cancer treatment
- In conclusion, as chronic diseases continue to rise, the demand for infusion pumps is expected to grow, ensuring better management of long-term patient care
Opportunity
“Growing Demand for Home Healthcare Solutions”
- The shift toward home healthcare services is creating a significant opportunity for the infusion pumps market
- Many patients with chronic conditions or those recovering from surgeries prefer receiving treatments at home, driving demand for portable and user-friendly infusion pumps
- Infusion pumps for home use are becoming smaller, more efficient, and easier to operate, allowing patients and caregivers to manage treatments independently
- For instance, insulin pumps are increasingly being used by diabetes patients in home settings to provide continuous medication, and chemotherapy patients are using home-based pumps for outpatient treatments
- The rising cost of hospital stays and the growing need to reduce healthcare expenditure make home healthcare a cost-effective alternative, encouraging infusion pump manufacturers to focus on home healthcare solutions
- In conclusion, as home healthcare continues to grow, there is significant potential for the expansion and innovation of infusion pump technologies tailored for home use
Restraint/Challenge
“High Cost of Infusion Pump Systems”
- A key restraint for the infusion pumps market is the high cost associated with purchasing and maintaining advanced infusion systems
- Smart and programmable infusion pumps are particularly expensive due to their advanced features such as wireless connectivity, real-time monitoring, and precise medication delivery
- For smaller healthcare facilities, clinics, and hospitals with limited budgets, the high upfront costs can be a significant financial burden, making it difficult to implement these systems
- Ongoing maintenance and servicing, including calibration, software updates, and repairs, add to the overall cost of these devices, further limiting their adoption in cost-sensitive settings
- For patients using infusion pumps for home healthcare, the costs can be prohibitively high, especially if insurance coverage is insufficient or absent, preventing wider access to modern infusion pump technologies
- To overcome this financial barrier, manufacturers must find ways to reduce production and maintenance costs, making these devices more affordable and accessible, which would foster broader market growth
North America Infusion Pumps Market Scope
The market is segmented on the basis of type, application, end user, product, and disease indication.
|
Segmentation |
Sub-Segmentation |
|
By Type |
|
|
By Application |
|
|
By End User |
|
|
By Product |
|
|
By Disease Indication |
|
In 2025, the Volumetric Infusion Pumps segment is projected to dominate the market with a largest share in product segment
The volumetric infusion pumps segment is expected to dominate the North America Infusion Pumps market with the largest share of 27.49% in 2025 due to their high accuracy in delivering large volumes of fluids, medications, and nutrients at controlled rates. These pumps are widely used in hospitals and clinical settings for critical care, oncology, and long-term therapies, where precise fluid administration is essential. Rising prevalence of chronic conditions such as cancer, diabetes, and cardiovascular diseases has led to increased hospital admissions, thereby driving demand.
The chemotherapy segment is expected to account for the largest share during the forecast period in disease indication segment
In 2025, the chemotherapy segment is expected to dominate the market with the largest market share of 9.33% due to the rising incidence of cancer, increasing adoption of infusion therapy for oncology treatment, and the growing availability of advanced infusion pump technologies that ensure precise and continuous drug delivery. In addition, the increasing preference for ambulatory and home-based chemotherapy, supported by favorable reimbursement frameworks and improvements in portable infusion devices, is further driving the segment’s growth.
North America Infusion Pumps Market Country Analysis
“North America Holds the Largest Share in the North America Infusion Pumps Market”
- The U.S. is the leader in the North American infusion pump market with 56.11% share due to its well-established healthcare system and cutting-edge medical technology, which drives the demand for advanced medical devices like infusion pumps
- Leading companies such as BD, Baxter, and Medtronic significantly contribute to the competitiveness and innovation in the U.S. market
- The increasing rates of chronic diseases, including diabetes, cancer, and cardiovascular issues, create a strong demand for infusion pumps to manage treatments effectively
- Infusion pumps are widely utilized in various healthcare settings such as hospitals, clinics, and home care, making them integral to patient care
- Continuous advancements in technology, such as smart pumps and wireless monitoring features, coupled with favorable healthcare policies, solidify the U.S.'s dominance in the infusion pump sector
“Mexico is Projected to Register the HighestCAGR in the North America Infusion Pumps Market”
- Mexico is experiencing rapid growth in the infusion pump market, spurred by substantial investments in healthcare infrastructure and increasing adoption of advanced medical technologies
- With urban areas expanding and healthcare access improving, more medical institutions are adopting infusion pumps, driving the market's expansion
- The Mexican government’s efforts to improve healthcare access through increased funding and policy initiatives contribute to the adoption of advanced medical devices, including infusion pumps
- The rising number of surgical procedures in Mexico, coupled with a growing demand for efficient and reliable medical equipment, is a key factor accelerating market growth
- Enhanced healthcare coverage, alongside public and private sector initiatives, ensures broader access to infusion pumps, which is pivotal to market expansion in the region
North America Infusion Pumps Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- BD (U.S.)
- Baxter (U.S.)
- Braun Medical Inc (Germany)
- ICU Medical (U.S.)
- Fresenius Kabi South Africa (Pty) Ltd (Germany)
- Smiths Medical (U.S.)
- Medtronic (Ireland)
- Moog Inc. (U.S.)
- AVNS (U.S.)
- NIPRO (Japan)
- Terumo Corporation (Japan)
- Insulet Corporation (U.S.)
- Ypsomed Holding AG (Switzerland)
- Tandem Diabetes Care Inc. (U.S.)
- JMS Co., Ltd. (Japan)
- Micrel Medical Devices SA (Greece)
- InfuTronix Solutions LLC (U.S.)
- Zyno Medical LLC (U.S.)
- Roche Diagnostics (Switzerland)
- Teleflex, Inc. (U.S.)
- Mindray Medical International Limited (China)
Latest Developments in North America Infusion Pumps Market
- In November 2024, ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. entered into a strategic joint venture aimed at bolstering supply chain resilience and driving innovation in the North American intravenous (IV) solutions market. This collaboration combines Otsuka’s vast global manufacturing expertise with ICU Medical’s robust production and distribution network across North America. Together, the two companies plan to provide cutting-edge IV pumps and consumables to healthcare providers, ensuring more reliable and efficient healthcare delivery
- In January 2024, Lemer Pax, a global leader in radiation protection technologies, entered into a partnership with ICU Medical, a renowned provider of infusion systems, to distribute the Plum 360 infusion pump in the French nuclear medicine sector. This collaboration is part of ICU Medical’s strategy to expand its footprint in the European market. The partnership aims to enhance the efficiency and safety of nuclear medicine treatments, positioning ICU Medical's Plum 360 as a key tool in the delivery of precise medication administration in specialized medical settings across Europe
- In October 2024, the South Korea infusion pumps market is projected to experience robust growth, with an estimated CAGR of 7.9% from 2024 to 2034. This growth is driven by increasing demand for advanced medical technologies, the rising prevalence of chronic diseases, and expanding healthcare infrastructure. The market is also benefitting from the growing adoption of smart infusion pumps in hospitals and homecare settings
- In August 2024, the North America infusion devices market was valued at approximately US$ 5.49 billion and is projected to reach US$ 9.12 billion by 2031, reflecting a 6.5% CAGR during the forecast period. This growth is driven by the increasing prevalence of chronic diseases such as cancer and diabetes, a rising geriatric population, and advancements in infusion device technologies. Notably, the infusion pumps segment is expected to lead the market, with innovations like Baxter's Novum IQ large volume infusion pump and BD's Alaris Infusion System enhancing safety and efficiency in clinical settings
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
